Postoperative Analgesis in Total Knee Arthroplasty
Results of Postoperative Analgesis Protocols Applied in Total Knee Arthroplasty:Observational Study
1 other identifier
observational
70
1 country
1
Brief Summary
Postoperative analgesic treatment methods are applied to patients who have undergone knee arthroplasty. These applications are a routine part of the procedure. It is medically and ethically necessary. Postoperative analgesia applications are started during the intraoperative period and continued during the postoperative period. The analgesia protocol to be used is shaped by the characteristics of the patient and the skill and experience of the anesthesiologist. The scientifically accepted method is multimodel analgesia protocols. These protocols cover a wide range from paracetamol to opioids to peripheral and central blocks (methods such as suprainguinal fascia iliac block (SFIP), adductor block (ACB) and infiltration analgesia (IPACK) applied between the posterior elements of the knee and the popliteal artery). Our aim in this study is to evaluate the effects of analgesia protocols applied to patients undergoing knee arthroplasty surgery on inflammatory biomarkers (such as neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR), systemic immune inflammation score (SII), lactate) obtained from routine blood and blood gas examinations in the first 24 hours of the postoperative period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 29, 2024
CompletedFirst Posted
Study publicly available on registry
July 12, 2024
CompletedStudy Start
First participant enrolled
July 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 4, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 5, 2024
CompletedNovember 25, 2024
July 1, 2024
2 months
June 29, 2024
November 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative pain
Pain levels of patients will be evaluated with the Numerical Pain Scale (NRS) in the first 24 hours postoperatively.
postoperative 24 hours
Secondary Outcomes (4)
inflammatory mediators
preoperative 24 hours
inflammatory mediators
preoperative 24 hours
inflammatory mediators
preoperative 24 hours
inflammatory mediators
preoperative 24 hours
Study Arms (2)
Group S
SFIP block will be applied for postoperative analgesic purposes
Group IP
SFIP block will be applied for postoperative analgesic purposes
Interventions
We apply different nerve blocks to patients for analgesic purposes after knee replacement surgery. These blocks are a combination of SFIP block and adductor channel block and iPACK block.
Eligibility Criteria
Among patients who had elective knee replacement surgery, those who underwent postoperative nerve block
You may qualify if:
- years old
- ASA I,II,III patients
- Patients who will undergo elective surgery
You may not qualify if:
- Patients undergoing emergency surgery
- Patients with bleeding diathesis
- Those who are allergic or sensitive to local anesthetics and opioid drugs,
- Those who use gabapentinoids
- Patients with neurocognitive disorders,
- Patients with chronic organ failure,
- Mothers with suspected pregnancy, pregnant or breastfeeding mothers
- Patients using opioids
- Those who use steroids
- Those with a history of substance use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Senay Caniklilead
Study Sites (1)
SAMSUN UNIVERSITY Samsun Training and research hospital
Samsun, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Senay canikli adıgüzel
Samsun University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
June 29, 2024
First Posted
July 12, 2024
Study Start
July 22, 2024
Primary Completion
October 4, 2024
Study Completion
October 5, 2024
Last Updated
November 25, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share
Participants' data will not be shared. After the study is written as an article, it can be shared if the editor of the journal wishes